Scilex Holding Stock Today
| SCLX Stock | 0.64 0.03 4.92% |
Performance0 of 100
| Odds Of DistressOver 81
|
Scilex Holding is trading at 0.64 as of the 2nd of December 2024; that is 4.92% up since the beginning of the trading day. The stock's open price was 0.61. Scilex Holding has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Scilex Holding are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of September 2023 and ending today, the 2nd of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 5th of March 2021 | Category Healthcare | Classification Health Care |
Scilex Holding is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 133.92 M outstanding shares of which 5.4 M shares are at this time shorted by private and institutional investors with about 1.65 trading days to cover. More on Scilex Holding
Moving together with Scilex Stock
Moving against Scilex Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Scilex Stock Highlights
| CEO President | Jaisim Shah | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-General, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsScilex Holding can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Scilex Holding's financial leverage. It provides some insight into what part of Scilex Holding's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scilex Holding (SCLX) is traded on NASDAQ Exchange in USA. It is located in 960 San Antonio Road, Palo Alto, CA, United States, 94303 and employs 113 people. Scilex Holding is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 86.19 M. Scilex Holding conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 133.92 M outstanding shares of which 5.4 M shares are at this time shorted by private and institutional investors with about 1.65 trading days to cover.
Scilex Holding generates negative cash flow from operations
Check Scilex Holding Probability Of Bankruptcy
Ownership AllocationScilex Holding shows a total of 133.92 Million outstanding shares. Scilex Holding maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Scilex Ownership Details
Scilex Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Hhg Plc | 2024-09-30 | 534.3 K | |
| Norges Bank | 2024-06-30 | 477.6 K | |
| Jpmorgan Chase & Co | 2024-09-30 | 435.7 K | |
| Jane Street Group Llc | 2024-06-30 | 277.4 K | |
| Squarepoint Ops Llc | 2024-09-30 | 265 K | |
| Ra Capital Management, Llc | 2024-09-30 | 261.2 K | |
| Lmr Partners Llp | 2024-09-30 | 213.4 K | |
| Cvi Holdings Llc | 2024-06-30 | 212.6 K | |
| Barclays Plc | 2024-09-30 | 195.5 K | |
| State Street Corp | 2024-09-30 | 7.5 M | |
| Blackrock Inc | 2024-06-30 | 6.7 M |
Scilex Holding Historical Income Statement
Scilex Stock Against Markets
Scilex Holding Corporate Management
| Steven JD | Interim Officer | Profile | |
| Gigi DeGuzman | Executive Resources | Profile | |
| Dmitri MD | Senior Officer | Profile | |
| Sumant Rajendran | Executive Marketing | Profile |
Additional Tools for Scilex Stock Analysis
When running Scilex Holding's price analysis, check to measure Scilex Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scilex Holding is operating at the current time. Most of Scilex Holding's value examination focuses on studying past and present price action to predict the probability of Scilex Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scilex Holding's price. Additionally, you may evaluate how the addition of Scilex Holding to your portfolios can decrease your overall portfolio volatility.